What is the Marbofloxacin?

Marbofloxacin is yellow or primrose yellow powder, while it's Molecular Formula is C17H19FN4O4. yellow or primrose yellow powder A broad spectrum antibiotic commonly used to target Pseudomonas and Staphylococci species

What is the CAS number for Marbofloxacin?

The CAS number of Marbofloxacin is 115550-35-1.

What is Marbofloxacin (115550-35-1) used for?

Marbofloxacin is a fluoroquinolone antibiotic that is active against P. multocida in vitro (MIC = 0.016 μg/ml). It exhibits broad-spectrum antibacterial activity mediated by the inhibition of DNA gyrase, with MIC values ranging from 0.016 to 0.4 and 0.19 to 1.7 μg/ml against various Gram-negative and Gram-positive bacterial isolates, respectively. In vivo, the administration of marbofloxacin (2 mg/kg, i.m.) after infection prevents the formation of pulmonary lesions in a bovine calf model of M. haemolytica A1 pneumonia. Oral marbofloxacin (2 mg/kg per day) also exhibits antileishmanial activity in a canine model of leishmaniasis, decreasing parasitic load by 72%. Formulations containing marbofloxacin have been used in the veterinary treatment of bacterial infections.InChI:InChI=1/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25)

What is the Marbofloxacin?

Marbofloxacin is yellow or primrose yellow powder, while it's Molecular Formula is C17H19FN4O4. yellow or primrose yellow powder A broad spectrum antibiotic commonly used to target Pseudomonas and Staphylococci species

What is the CAS number for Marbofloxacin?

The CAS number of Marbofloxacin is 115550-35-1.

What is Marbofloxacin (115550-35-1) used for?

Marbofloxacin is a fluoroquinolone antibiotic that is active against P. multocida in vitro (MIC = 0.016 μg/ml). It exhibits broad-spectrum antibacterial activity mediated by the inhibition of DNA gyrase, with MIC values ranging from 0.016 to 0.4 and 0.19 to 1.7 μg/ml against various Gram-negative and Gram-positive bacterial isolates, respectively. In vivo, the administration of marbofloxacin (2 mg/kg, i.m.) after infection prevents the formation of pulmonary lesions in a bovine calf model of M. haemolytica A1 pneumonia. Oral marbofloxacin (2 mg/kg per day) also exhibits antileishmanial activity in a canine model of leishmaniasis, decreasing parasitic load by 72%. Formulations containing marbofloxacin have been used in the veterinary treatment of bacterial infections.InChI:InChI=1/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25)

Cost-effective and customizable Marbofloxacin 115550-35-1 supplier

Product NameMarbofloxacin
CasNo. 115550-35-1
MFC₁₇H₁₉FN₄O₄
MW362.36
Purity
Appearanceyellow or primrose yellow powder
Packing
Contact usInquiry

Product Details

CasNo： 115550-35-1

MF： C₁₇H₁₉FN₄O₄

Appearance： yellow or primrose yellow powder